Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment - Outcome Results from the CLL13/GAIA Trial

Autor: Eugen Tausch, Christof Schneider, Moritz Furstenau, Sandra Robrecht, Deyan Yordanov Yosifov, Daniel Mertens, Michael Gregor, Patrick Thornton, Philipp B. Staber, Tamar Tadmor, Mark-David Levin, Caspar da Cunha-Bang, Christian Bjørn Poulsen, Thomas Illmer, Björn Schöttker, Ann Janssens, Ilse Christiansen, Thomas Noesslinger, Michael Baumann, Clemens-Martin Wendtner, Eric Eldering, Karl-Anton Kreuzer, Matthias Ritgen, Anna-Maria Fink, Kirsten Fischer, Arnon P. Kater, Carsten Utoft Niemann, Michael Hallek, Barbara Eichhorst, Stephan Stilgenbauer
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Tausch, E, Schneider, C, Furstenau, M, Robrecht, S, Yosifov, D Y, Mertens, D, Gregor, M, Thornton, P, Staber, P B, Tadmor, T, Levin, M-D, da Cunha-Bang, C, Poulsen, C B, Illmer, T, Schöttker, B, Janssens, A, Christiansen, I, Noesslinger, T, Baumann, M, Wendtner, C-M, Eldering, E, Kreuzer, K-A, Ritgen, M, Fink, A-M, Fischer, K, Kater, A P, Niemann, C U, Hallek, M, Eichhorst, B & Stilgenbauer, S 2022, ' Genetic Markers and Front Line FCR/BR Vs. Rve, Gve and Give Treatment-Outcome Results from the CLL13/GAIA Trial ', Blood, vol. 140, no. Suppl. 1, 642, pp. 839–841 . https://doi.org/10.1182/blood-2022-163775
DOI: 10.1182/blood-2022-163775
Databáze: OpenAIRE